Treatment of post-kala-azar dermal leishmaniasis with methyl glucamine antimoniate.
D000965:Antimony / Q000627:therapeutic use*; D006801:Humans; D007896:Leishmaniasis / Q000628:therapy*; D007898:Leishmaniasis, Visceral
D000965:Antimony
ANTIMONY/therapeutic use; LEISHMANIASIS/therapy